Related Experiment Video
Updated: Feb 25, 2026
07:30
Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
Published on: May 10, 2018
9.8K
Point-of-Care Endocrine Diagnostics.
1i-calQ LLC, 466 North Wall Street, Salt Lake City, UT 84103, USA; Division of Endocrinology, Department of Medicine, University of Colorado School of Medicine, 13001 East 17th Place, Aurora, CO 80045, USA.
Endocrinology and Metabolism Clinics of North America
|August 2, 2017
Summary
Point-of-care endocrine diagnostics are revolutionizing healthcare by offering rapid, cost-effective hormone and metabolite measurements. This technology brings lab-quality results from central labs to the patient
Area of Science:
- Endocrinology and Clinical Diagnostics
- Biomedical Engineering and Microfluidics
Background:
- Endocrinology necessitates precise hormone and metabolite measurement for public health, diagnostics, and disease management.
- Traditional laboratory-based endocrine testing presents limitations in speed and accessibility.
Purpose of the Study:
- To highlight the shift of in vitro endocrine diagnostics from centralized laboratories to point-of-care settings.
- To emphasize the benefits of point-of-care endocrine diagnostics, including cost-effectiveness and rapid results.
Main Methods:
- Integration of microfluidics, immunoassay technology, electronics, and software.
- Development of point-of-care devices for endocrine testing.
Main Results:
- Point-of-care endocrine diagnostics achieve clinically equivalent results to laboratory instrumentation.
- These devices offer significant cost reductions and substantially faster turnaround times.
- The evolution mirrors the transition from mainframe computers to personal devices.
Conclusions:
- Point-of-care technologies are transforming clinical laboratories in endocrinology.
- This advancement democratizes access to essential endocrine testing, improving patient care and public health screening.
Related Concept Videos
01:45Endocrine Signaling
68.5K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.5K
01:15Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K
01:16Hormones Regulating Blood Glucose
7.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.4K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
01:25Insulin: Biosynthesis, Chemistry, and Preparation
1.6K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.6K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K